News About ATRIAL FIBRILLATION

Tempus AIs ECG-AF Software Passes Multi-Site Validation, Backing FDA Clearance

Tempus AI, the precision‑medicine startup that listed on Nasdaq last June, has just confirmed that its AI‑powered electrocardi...